Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19 : current evidence and potential mechanisms
Errataetall: |
CommentOn: Mol Psychiatry. 2021 Dec;26(12):7091-7092. - PMID 34282263 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Molecular psychiatry - 26(2021), 12 vom: 12. Dez., Seite 7098-7099 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hoertel, Nicolas [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antidepressive Agents |
---|
Anmerkungen: |
Date Completed 01.03.2022 Date Revised 26.10.2022 published: Print-Electronic CommentOn: Mol Psychiatry. 2021 Dec;26(12):7091-7092. - PMID 34282263 Citation Status MEDLINE |
---|
doi: |
10.1038/s41380-021-01254-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329294180 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329294180 | ||
003 | DE-627 | ||
005 | 20231225204813.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41380-021-01254-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329294180 | ||
035 | |a (NLM)34385600 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hoertel, Nicolas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19 |b current evidence and potential mechanisms |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2022 | ||
500 | |a Date Revised 26.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: Mol Psychiatry. 2021 Dec;26(12):7091-7092. - PMID 34282263 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 7 | |a Antidepressive Agents |2 NLM | |
650 | 7 | |a Ceramides |2 NLM | |
650 | 7 | |a Sphingomyelin Phosphodiesterase |2 NLM | |
650 | 7 | |a EC 3.1.4.12 |2 NLM | |
650 | 7 | |a Rimonabant |2 NLM | |
650 | 7 | |a RML78EN3XE |2 NLM | |
700 | 1 | |a Sánchez-Rico, Marina |e verfasserin |4 aut | |
700 | 1 | |a Cougoule, Céline |e verfasserin |4 aut | |
700 | 1 | |a Gulbins, Erich |e verfasserin |4 aut | |
700 | 1 | |a Kornhuber, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Carpinteiro, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Becker, Katrin Anne |e verfasserin |4 aut | |
700 | 1 | |a Reiersen, Angela M |e verfasserin |4 aut | |
700 | 1 | |a Lenze, Eric J |e verfasserin |4 aut | |
700 | 1 | |a Seftel, David |e verfasserin |4 aut | |
700 | 1 | |a Lemogne, Cédric |e verfasserin |4 aut | |
700 | 1 | |a Limosin, Frédéric |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular psychiatry |d 1997 |g 26(2021), 12 vom: 12. Dez., Seite 7098-7099 |w (DE-627)NLM09062694X |x 1476-5578 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2021 |g number:12 |g day:12 |g month:12 |g pages:7098-7099 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41380-021-01254-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2021 |e 12 |b 12 |c 12 |h 7098-7099 |